Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Plasma anticonvulsant concentrations during pregnancy.

C M Lander, V E Edwards, M J Eadie

    Neurology
    |February 1, 1977
    PubMed
    Summary

    During pregnancy, epileptic women require higher doses of phenytoin anticonvulsants. Phenobarbital levels decreased, necessitating careful management to prevent seizures and overdosage.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Neurological factors and Cesarean section in Australian women with epilepsy.

    Epilepsy & behavior : E&B·2022
    Same author

    Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register.

    Seizure·2018
    Same author

    Antiepileptic drug polytherapy in pregnant women with epilepsy.

    Acta neurologica Scandinavica·2018
    Same author

    Predicting epileptic seizure control during pregnancy.

    Epilepsy & behavior : E&B·2017
    Same author

    Anti-epileptic drug exposure and risk of foetal death in utero.

    Acta neurologica Scandinavica·2017
    Same author

    Triptan use in Australia 1997-2015: A pharmacoepidemiological study.

    Acta neurologica Scandinavica·2017

    Area of Science:

    • Pharmacology
    • Neurology
    • Obstetrics

    Background:

    • Epilepsy management during pregnancy presents unique challenges due to physiological changes affecting drug metabolism and efficacy.
    • Understanding anticonvulsant pharmacokinetics is crucial for maintaining therapeutic levels and preventing adverse events in pregnant epileptic patients.

    Observation:

    • Plasma anticonvulsant levels were monitored in 11 epileptic women throughout pregnancy.
    • Phenytoin dosage requirements increased significantly during pregnancy in 10 out of 11 women.
    • Phenobarbital plasma levels decreased in all five women on a stable dose during pregnancy.

    Findings:

    • Phenytoin requirements increased during pregnancy, returning to baseline postpartum.
    • Phenobarbital levels decreased during pregnancy, indicating altered pharmacokinetics.
    • These changes highlight dynamic shifts in drug metabolism and elimination during gestation.

    Implications:

    • Adjusting anticonvulsant dosages is essential for seizure control in pregnant epileptic women.
    • Close monitoring is required to prevent potential anticonvulsant overdosage postpartum.
    • These findings inform clinical practice for optimizing epilepsy treatment during and after pregnancy.

    Related Experiment Videos